Cori Clinical
PrivateLast Round
Seed
Oct 7, 2026
Total Funding Raised
$4M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Cori Clinical operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Seed round in October 2026.
Cori Clinical is a healthtech company that provides an AI-powered workspace for clinical trial design, documentation, and operational planning.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Medical AI, Workflow Automation, Document Management
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cori Clinical Comparables
Compare Cori Clinical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Risklick AG | 90% | |
| Trialynx | 86% | |
| Ryght AI | 85% |
For institutional investors. Book with your work email.
Cori Clinical Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cori Clinical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Heartfelt | Seed |
| Ventures Together | Seed |
| Bynd Venture Capital | Seed |
| Breega | Seed |
| Enzo Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 7, 2026
$4M round led by Breega.
- Sep 22, 2026
Grew 50% QoQ, from 8 to 12 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- identified_as_competitor_ofOct 10, 2026
Cori Clinical is identified as a competitor of Lindus Health Limited in the United Kingdom’s clinical-trial technology market, where Lindus Health Limited is an established, better-funded rival, on Oct 10th '26.
For institutional investors. Book with your work email.
Cori Clinical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cori Clinical's valuation, stock price, and market status.
Is Cori Clinical a public or private company?
Cori Clinical is a private company.
What is the current stock price of Cori Clinical?
Cori Clinical is a private company, so its shares have no public market price. Caplight tracks Cori Clinical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cori Clinical worth (valuation)?
Valuation information for Cori Clinical is not publicly available.
Can I buy Cori Clinical stock?
Cori Clinical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cori Clinical's last funding round?
Cori Clinical's most recent funding round was Seed on October 7, 2026.
Who are the main investors in Cori Clinical?
Key investors in Cori Clinical include Breega.
Will Cori Clinical IPO soon?
No public IPO plans have been announced for Cori Clinical.
How can I track Cori Clinical secondary market activity?
Caplight tracks bids, offers, and trades in Cori Clinical's shares on secondary markets.